NanoViricides
NNVC
#10132
Rank
NZ$38.31 M
Marketcap
NZ$2.13
Share price
0.82%
Change (1 day)
-17.12%
Change (1 year)

Earnings for NanoViricides (NNVC)

Earnings in 2025 (TTM): -NZ$15.88 Million

According to NanoViricides's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -NZ$16.22 Million a decrease over its 2023 earnings that were of -NZ$16.2 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for NanoViricides from 2007 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$15.88 Million-2.09%
2024 -NZ$16.22 Million0.09%
2023 -NZ$16.2 Million35.83%
2022 -NZ$11.93 Million-20.96%
2021 -NZ$15.09 Million-40.3%
2020 -NZ$25.28 Million86.2%
2019 -NZ$13.58 Million0.09%
2018 -NZ$13.56 Million-25.39%
2017 -NZ$18.18 Million-6.68%
2016 -NZ$19.48 Million114.25%
2015 -NZ$9.09 Million-5.43%
2014 -NZ$9.62 Million-59.73%
2013 -NZ$23.87 Million106.16%
2012 -NZ$11.58 Million5.57%
2011 -NZ$10.97 Million6.42%
2010 -NZ$10.31 Million93.61%
2009 -NZ$5.33 Million-4.07%
2008 -NZ$5.55 Million19.12%
2007 -NZ$4.66 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
BioCryst Pharmaceuticals
BCRX
-NZ$11.46 Million-30.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
NZ$0.64 B-4,061.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$17.11 B-104,526.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$13.90 B-84,952.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$39.96 B-244,000.64%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$16.13 B-98,578.18%๐Ÿ‡ฌ๐Ÿ‡ง UK